Ainnocence
Ainnocence provides an AI-driven platform to speed up drug discovery and reduce discovery costs. The system combines virtual screening, scientific intelligence, and molecular generative AI. It performs high-throughput computational screening, evaluating up to 10^10 protein sequences or compounds within hours, guiding wet-lab experiments with high hit rates. The platform supports small molecules, antibodies, CAR-T and other modalities for multi-objective pharmacological optimization. This B2B technology aims to cut development time and costs for biotech and pharmaceutical companies.
Ainnocence
Ainnocence provides an AI-driven platform to speed up drug discovery and reduce discovery costs. The system combines virtual screening, scientific intelligence, and molecular generative AI. It performs high-throughput computational screening, evaluating up to 10^10 protein sequences or compounds within hours, guiding wet-lab experiments with high hit rates. The platform supports small molecules, antibodies, CAR-T and other modalities for multi-objective pharmacological optimization. This B2B technology aims to cut development time and costs for biotech and pharmaceutical companies.
